A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning.

CONCLUSIONS: These results indicate that consistent antipsychotic medication adherence and cognitive remediation can significantly improve core cognitive deficits in the initial period of schizophrenia. When combined with supported employment/education, cognitive remediation and LAI antipsychotic medication show separate significant impact on improving work/school functioning. PMID: 32981534 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32981534?dopt=Abstract

Source: Psychological Medicine - September 27, 2020 Category: Psychiatry Authors: Nuechterlein KH, Ventura J, Subotnik KL, Gretchen-Doorly D, Turner LR, Casaus LR, Luo J, Boucher ML, Hayata JN, Bell MD, Medalia A Tags: Psychol Med Source Type: research